Search results
Results from the WOW.Com Content Network
It has a variety of cutaneous side effects, particularly when administered in high doses. [44] Another little-understood but serious possible adverse effect of methotrexate is neurological damage and memory loss. [45] Neurotoxicity may result from the drug crossing the blood–brain barrier and damaging neurons in the cerebral cortex.
[2] [3] For acute lymphocytic leukemia it is generally used with methotrexate. [2] It is taken orally. [2] Common side effects include bone marrow suppression, liver toxicity, vomiting, and loss of appetite. [2] Other serious side effects include an increased risk of future cancer and pancreatitis. [2]
Sulfonylureas — effects enhanced; Phenytoin, half-life of phenytoin is increased; Antifolates like pyrimethamine, proguanil and methotrexate increase the risk of associated side effects like bone marrow toxicity, folic acid supplementation should be considered. A significant risk of megaloblastic anaemia exists with doses of pyrimethamine in ...
Folinic acid, also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate and pyrimethamine. [2] [3] It is also used in combination with 5-fluorouracil to treat colorectal cancer and pancreatic cancer, may be used to treat folate deficiency that results in anemia, and methanol poisoning.
Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. [6] Regeneron Pharmaceuticals and Sanofi developed the drug for the treatment of rheumatoid arthritis (RA), for which it received US FDA approval on 22 May 2017 and European Medicines Agency approval on 23 June 2017.
Common side effects include diarrhea and abdominal pain. [11] It is in pregnancy category X, meaning that it is known to result in negative outcomes for the fetus if taken during pregnancy. [11] In rare cases, uterine rupture may occur. [11] It is a prostaglandin analogue—specifically, a synthetic prostaglandin E 1 (PGE 1). [11]
This increases the length of time which the Cl − ionopores are open, thus causing an inhibitory effect. Metabolism of methohexital is primarily hepatic via demethylation and oxidation. [1] Side-chain oxidation is the primary means of metabolism involved in the termination of the drug's biological activity.
Serious side effects include agranulocytosis, aplastic anaemia, hypersensitivity reactions (like anaphylaxis and bronchospasm), toxic epidermal necrolysis and it may provoke acute attacks of porphyria, as it is chemically related to the sulfonamides.